The Valley Desk

Clinical trial reportCellPublished

The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM

36 of 50 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Cell
Published
Subject terms
Killer Cells, Natural; Humans; Glioblastoma; Brain Neoplasms; Neoplasm Recurrence, Local; Immunotherapy, Adoptive; T-Lymphocytes, Regulatory; Receptors, Chimeric Antigen; Immunotherapy; NK cells; Biomarkers; immunology
PubMed ID
42296961
PubMed Central ID
PMC13401735
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal